Skip to main content
 

News

 

Akribion Therapeutics GmbH has signed its inaugural seed financing round for €8m

28 Nov 2024

RIG client Akribion Therapeutics has successfully completed an €8m seed financing round, supported by a syndicate of investors made up of CARMA FUND Management GmbH; RV Invest; MP Beteiligungs GmbH; BMH Beteiligungs-Management Hessen; Bruker Invest AG 
 

Liberation Labs has completed 60% of its plant build

Senior Engagement Manager

13 Nov 2024

RIG client Liberation Labs is accelerating towards plant completion, with first customer runs expected in the second half of 2025.
 

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology

Partner
Director

31 Oct 2024

RIG client Akribion Therapeutics is progressing the development of the CRISPR-Cas9 technology, with initial applications in oncology 
 

Agricarbon features in Countryfile magazine alongside partners

Practice Director

01 Oct 2024

The eight-page article spotlights Agricarbon in its discussion on 'guilt-free meat'
 

ClearLeaf Inc. Partners with Summit Agro International to Bring GotaBlanca® to Japan and South Korea

Partner

14 Aug 2024

After nearly three years of joint testing with RIG client ClearLeaf on a variety of pathogens in crops of commercial importance, Summit Agro International has acquired exclusive rights for the market development and distribution of ClearLeaf's flagship product, GotaBlanca, in Japan and South Korea